Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00790972
Other study ID # 15419A
Secondary ID
Status Withdrawn
Phase N/A
First received November 13, 2008
Last updated May 19, 2016
Start date June 2007
Est. completion date June 2013

Study information

Verified date May 2016
Source University of Chicago
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This is a study to assess the ability of SinoFresh Nasal & Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2013
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years or older

- The volunteer is able to adhere to the study requirements and study visits.

- Agrees to abstain from use of other nasal sprays for length of study.

- Diagnosis of an MRSA carrier by PCR testing

Exclusion Criteria:

- History of chronic nose bleeds.

- History of intranasal steroids in the last 2 months

- Nasal obstruction severe enough to prohibit effective delivery of a nasal spray

- Epistaxis

- Significant excoriation in the opinion of the Investigator.

- Known hypersensitivity to any ingredients

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Sinofresh
two sprays in each nostril three times daily for one week
Placebo
two sprays in each nostril three times daily for one week

Locations

Country Name City State
United States The University of Chicago Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary This is a study to assess the ability of SinoFresh Nasal & Sinus Care, an FDA approved over-the-counter nasal spray, to eliminate the bacteria in your nose. 7 days No
See also
  Status Clinical Trial Phase
Completed NCT00448942 - The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections N/A
Completed NCT00685867 - Two Strategies for Methicillin-resistant Staphylococcus Aureus (MRSA) Infection Prevention in Surgical Patients N/A
Withdrawn NCT00766259 - Relationship of Staphylococcal Colonization to Infection
Completed NCT00731783 - Staphylococcus Aureus Decolonization Study N/A
Completed NCT00711854 - Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection Phase 4
Not yet recruiting NCT01724671 - Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline N/A
Recruiting NCT00502476 - Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections N/A
Completed NCT01814371 - Individualized vs. Household MRSA Decolonization N/A